BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 25, 2014
View Archived Issues
The Vanderbilt University prepares new mAChR modulators
Read More
Novel O-GlcNAcase inhibitors disclosed by Alectos and Merck & Co.
Read More
Washington University School of Medicine to assess EDI-200 in rare genetic disorder
Read More
Pharnext's PXT-3003 obtains FDA orphan drug status
Read More
Phase III results demonstrate noninferiority of tofacitinib to etanercept in psoriasis patients
Read More
NDA for Zacras fixed-dose combination tablet for hypertension approved in Japan
Read More
FDA grants orphan drug status to Chatham Therapeutics' hemophilia B treatment
Read More
New influenza treatment Avigan approved in Japan
Read More
Researchers in India design novel agents for MDR bacterial infections
Read More
Novartis divulges new S. aureus vaccines
Read More
Laminin-gamma2 as a novel biomarker for bladder cancer
Read More
First evaluation in humans of a new necrosis inhibitor, LC28-0126
Read More
Ajinomoto Pharmaceuticals obtains approval for valsartan/cilnidipine combination in Japan
Read More
Takeda Pharmaceutical receives positive CHMP opinion for Entyvio
Read More
Tapenta receives Japanese approval for cancer pain
Read More
Takelda combination tablets approved in Japan
Read More
Novel erythropoiesis-stimulating agent GC-1113 shows efficacy in humans
Read More
CHMP recommends approval of empagliflozin for type 2 diabetes
Read More
Siltuximab receives positive CHMP opinion supporting approval in multicentric Castleman's disease
Read More
Tivicay obtains approval in Japan for HIV
Read More
FDA grants fast track designation to NeuroVax for secondary progressive MS
Read More
KB-39 as novel peptidomimetic of Bcl-2 proteins for prostate cancer
Read More
Forxiga receives regulatory approval in Japan for type 2 diabetes
Read More
Japanese approval of Lusefi for type 2 diabetes
Read More
Mochida announces Japanese approval of Treprost for PAH
Read More
CytRx initiates phase III trial of aldoxorubicin for soft tissue sarcoma
Read More
Arrowhead conducting phase IIa study of ARC-520 to treat chronic HBV infection
Read More